OPKO Health and Pfizer report positive Phase III data for somatrogon

Pfizer partnered with OPKO Health in 2014 to develop and commercialise somatrogon. Credit: Jim.henderson.



  • OPKO Health, Pfizer report positive Phase III data for somatrogon